EFG Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.94M | Buy |
135,850
+12,908
| +10% | +$469K | 0.7% | 47 |
|
|
2025
Q1 | $4.45M | Sell |
122,942
-16,501
| -12% | -$598K | 0.74% | 36 |
|
|
2024
Q4 | $5.86M | Buy |
139,443
+30,055
| +27% | +$1.26M | 0.8% | 28 |
|
|
2024
Q3 | $6.07M | Sell |
109,388
-16,173
| -13% | -$898K | 1.02% | 14 |
|
|
2024
Q2 | $5.16M | Buy |
125,561
+8,725
| +7% | +$359K | 0.89% | 21 |
|
|
2024
Q1 | $5.45M | Buy |
116,836
+48,368
| +71% | +$2.26M | 0.94% | 20 |
|
|
2023
Q4 | $3.27M | Buy |
68,468
+10,547
| +18% | +$504K | 0.62% | 60 |
|
|
2023
Q3 | $2.07M | Buy |
57,921
+4,250
| +8% | +$152K | 0.49% | 66 |
|
|
2023
Q2 | $2.48M | Sell |
53,671
-5,758
| -10% | -$266K | 0.53% | 64 |
|
|
2023
Q1 | $2.38M | Buy |
+59,429
| New | +$2.38M | 0.53% | 62 |
|